XRAY DENTSPLY SIRONA Inc.

Dentsply Sirona Declares Quarterly Cash Dividend

Dentsply Sirona Declares Quarterly Cash Dividend

CHARLOTTE, N.C., May 21, 2020 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (NASDAQ: XRAY), The Dental Solutions Company™, announced that its Board of Directors declared a quarterly cash dividend of $0.10 per share of common stock, an indicated annual rate of $0.40 per share.  The dividend is payable on July 10, 2020 to holders of record on June 26, 2020.

About Dentsply Sirona:

Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide.  Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands.  As The Dental Solutions Company™, Dentsply Sirona’s products provide innovative, high-quality and effective solutions to advance patient care and deliver better, safer and faster dentistry.  Dentsply Sirona’s global headquarters is located in Charlotte, North Carolina. The company’s shares are listed in the United States on NASDAQ under the symbol XRAY.  Visit for more information about Dentsply Sirona and its products.

Contact Information:

John P. Sweeney, CFA, IRC

VP, Investor Relations

Dentsply Sirona Inc.

1-717-849-7863

EN
21/05/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DENTSPLY SIRONA Inc.

 PRESS RELEASE

First-ever Dental Dedicated MRI Validated in Clinical Trial and Cleare...

First-ever Dental Dedicated MRI Validated in Clinical Trial and Cleared by FDA for Advanced Soft-Tissue Diagnostics Dentsply Sirona and Siemens Healthineers are pleased to announce that the first-ever dental-dedicated MRI1 (ddMRI) system – MAGNETOM Free.Max Dental Edition – has received FDA clearance in the United States. This milestone follows the completion of a clinical trial2 validating the system’s significant potential across multiple dental specialties. The trial highlighted this first-of-its-kind technology’s applicability in endodontics, periodontics, TMJ, tooth extraction, and ort...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: March 7, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Dentsply Sirona Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 2 March 2026 in which we reassessed the appropriateness of the ratings in the context ...

Dentsply Sirona Inc: 2 directors

Two Directors at Dentsply Sirona Inc bought/maiden bought 55,000 shares at between 13.469USD and 14.148USD. The significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company'...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch